Arcutis Biotherapeutics, Inc. (ARQT)
23.90
+0.24
(+1.01%)
USD |
NASDAQ |
Sep 04, 16:00
24.50
+0.60
(+2.51%)
After-Hours: 20:00
Arcutis Biotherapeutics SG&A Expense (TTM) : 297.60M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 297.60M |
| March 31, 2026 | 284.63M |
| December 31, 2025 | 274.55M |
| September 30, 2025 | 253.18M |
| June 30, 2025 | 249.60M |
| March 31, 2025 | 238.60M |
| December 31, 2024 | 229.39M |
| September 30, 2024 | 220.46M |
| June 30, 2024 | 209.24M |
| March 31, 2024 | 197.02M |
| December 31, 2023 | 185.14M |
| September 30, 2023 | 173.49M |
| June 30, 2023 | 161.37M |
| March 31, 2023 | 143.04M |
| December 31, 2022 | 122.12M |
| September 30, 2022 | 103.83M |
| Date | Value |
|---|---|
| June 30, 2022 | 84.83M |
| March 31, 2022 | 68.52M |
| December 31, 2021 | 60.97M |
| September 30, 2021 | 48.93M |
| June 30, 2021 | 38.02M |
| March 31, 2021 | 32.32M |
| December 31, 2020 | 21.34M |
| September 30, 2020 | 16.88M |
| June 30, 2020 | 13.62M |
| March 31, 2020 | 9.33M |
| December 31, 2019 | 6.61M |
| September 30, 2019 | 4.979M |
| June 30, 2019 | 3.293M |
| March 31, 2019 | 1.969M |
| December 31, 2018 | 1.22M |
| September 30, 2018 | 0.614M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 620.29M |
| Insmed, Inc. | 893.58M |
| Emergent BioSolutions, Inc. | 181.20M |
| Exelixis, Inc. | 533.92M |
| Vertex Pharmaceuticals, Inc. | 2.008B |